Literature DB >> 17112208

Long-term outcome after STA-MCA anastomosis for moyamoya disease.

S Miyamoto1, Y Akiyama, I Nagata, J Karasawa, K Nozaki, N Hashimoto, H Kikuchi.   

Abstract

A long-term assessment was performed to determine the posttreatment clinical course of 113 patients with moyamoya disease. All patients sustained cerebral ischemic attacks and underwent superficial temporal artery-middle cerebral artery anastomosis with or without temporal muscle grafting. The follow-up duration was 3 to 24 years (mean 14.4 +/- 5.8 [standard deviation]). Complete cessation of the ischemic episodes was obtained in 110 of 113 patients. One hundred patients were able to return to independent acitvities of daily living. Intellectual delays prevented 24 patients from engaging in an independent social life . Although intracranial bleeding is one of the common manifestations in moyamoya disease, hemorrhage was not detected in the 113 patients who underwent cerebral revascularization.

Entities:  

Year:  1998        PMID: 17112208     DOI: 10.3171/foc.1998.5.5.8

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  10 in total

1.  A Panel of Exosome-Derived miRNAs of Cerebrospinal Fluid for the Diagnosis of Moyamoya Disease.

Authors:  Gang Wang; Yunyu Wen; Oluwasijibomi Damola Faleti; Qingshun Zhao; Jingping Liu; Guozhong Zhang; Mingzhou Li; Songtao Qi; Wenfeng Feng; Xiaoming Lyu
Journal:  Front Neurosci       Date:  2020-09-25       Impact factor: 4.677

Review 2.  Asymptomatic moyamoya disease: literature review and ongoing AMORE study.

Authors:  Satoshi Kuroda
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

Review 3.  Cognitive Outcome of Pediatric Moyamoya Disease.

Authors:  Kyu-Won Shim; Eun-Kyung Park; Ju-Seong Kim; Dong-Seok Kim
Journal:  J Korean Neurosurg Soc       Date:  2015-06-30

4.  Zigzag skin incision effectively camouflages the scar and alopecia for moyamoya disease: technical note.

Authors:  Yasuhiro Sanada; Tomonari Yabuuchi; Hiromasa Yoshioka; Hisashi Kubota; Amami Kato
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

Review 5.  Moyamoya Disease: Treatment and Outcomes.

Authors:  Tackeun Kim; Chang Wan Oh; Jae Seung Bang; Jeong Eun Kim; Won-Sang Cho
Journal:  J Stroke       Date:  2016-01-29       Impact factor: 6.967

6.  Voxel Based Analysis of Surgical Revascularization for Moyamoya Disease: Pre- and Postoperative SPECT Studies.

Authors:  Yasutaka Fushimi; Tomohisa Okada; Yasushi Takagi; Takeshi Funaki; Jun C Takahashi; Susumu Miyamoto; Kaori Togashi
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

Review 7.  Late Cerebrovascular Events and Social Outcome after Adolescence: Long-term Outcome of Pediatric Moyamoya Disease.

Authors:  Takeshi Funaki; Jun C Takahashi; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-05-21       Impact factor: 1.742

8.  Measurement of Intraoperative Graft Flow Predicts Radiological Hyperperfusion during Bypass Surgery in Patients with Moyamoya Disease.

Authors:  Akikazu Nakamura; Akitsugu Kawashima; Shunsuke Nomura; Takakazu Kawamata
Journal:  Cerebrovasc Dis Extra       Date:  2020-07-29

9.  Characterizing the neurocognitive profiles of children with moyamoya disease using the Das Naglieri cognitive assessment system.

Authors:  Yusuke Kusano; Takeshi Funaki; Keita Ueda; Noyuri Nishida; Kanade Tanaka; Susumu Miyamoto; Shuichi Matsuda
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

10.  Moyamoya disease and pregnancy: case reports and criteria for successful vaginal delivery.

Authors:  Kiguna Sei; Hidenori Sasa; Kenichi Furuya
Journal:  Clin Case Rep       Date:  2015-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.